RECTAL CANCER RECURRENT
Clinical trials for RECTAL CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new RECTAL CANCER RECURRENT trials appear
Sign up with your email to follow new studies for RECTAL CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New teamwork approach aims to make High-Risk cancer surgery safer
Disease control ENROLLING_BY_INVITATIONThis study aims to improve outcomes for patients undergoing complex pelvic cancer surgery by creating standardized procedures and better teamwork among specialists. It focuses on patients with advanced or returning rectal cancer that has spread to nearby organs, requiring major s…
Matched conditions: RECTAL CANCER RECURRENT
Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Trial halted before start for rectal cancer recurrence
Disease control TerminatedThis study aimed to test if a combination of two drugs, regorafenib and lorigerlimab, could shrink rectal cancer tumors that had started to grow back or returned locally after a patient's first round of treatment. The goal was to see if this drug combo could reduce the cancer eno…
Matched conditions: RECTAL CANCER RECURRENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC